Q32 Bio Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 855.4% | – | – | – | – | – | – | – | – | -11.5% | – | – | -36.9% | |
| 6.7% | – | – | – | – | – | – | – | – | 0.2% | – | – | 0.7% | |
| 16.2% | – | – | – | – | – | – | – | – | 2.7% | – | – | 10.9% | |
| 1,243.2% | – | – | – | – | – | – | – | – | -0.4% | – | – | 7.6% | |
| 0.1% | – | – | – | – | – | – | – | – | 0.0% | – | – | 0.0% | |
| -0.1% | – | – | – | – | – | – | – | – | 13.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -2.9% | – | – | -24.1% | |
| 16.1% | – | – | – | – | – | – | – | – | -2.9% | – | – | 119.6% | |
| -2,565.1% | – | – | – | – | – | – | – | – | -1.4% | – | – | 95.7% | |
| 855.3% | – | – | – | – | – | – | – | – | -11.5% | – | – | -36.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.